Physician profile
Stephen Dule
NPI 1699871178
$326.77
in general payments reported to CMS, 2019-2025
12 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.86 · 2022: $40.14 · 2023: $29.46 · 2024: $51.63 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $104.69 | 2022-2025 | |
| Ethicon US, LLC | $40.89 | 2021-2025 | Stratafix, Ethicon, Vistaseal |
| Bioventus LLC | $30.95 | 2021-2022 | |
| Orthofix Medical, INC. | $29.66 | 2021-2025 | Physio-Stim |
| Electronic Waveform Lab, INC. | $25.93 | 2025 | |
| Novus Surgical Consultants | $18.79 | 2024 | |
| Avanos Medical | $16.34 | 2024 | Grpro 2.1 |
| Solventum Corporation | $14.04 | 2025 | Prevena |
| Endo Pharmaceuticals INC. | $13.81 | 2021 | |
| Radius Health, INC. | $13.37 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2023 | Seglentis |
| Heraeus Medical, LLC. | $5.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dule listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.